These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 33020988)

  • 21. COVID-19 Pandemic-Related Practices and Policies Affecting the Continuity of Behavioral Health Care Among Children With Diabetes.
    Clary L; Wang C; Byrne ME; Monaghan M
    Transl Behav Med; 2020 Oct; 10(4):819-826. PubMed ID: 32710626
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Syndemic Perspective on the Management of Non-communicable Diseases Amid the COVID-19 Pandemic in Low- and Middle-Income Countries.
    Yadav UN; Rayamajhee B; Mistry SK; Parsekar SS; Mishra SK
    Front Public Health; 2020; 8():508. PubMed ID: 33102414
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Macrolevel association of COVID-19 with non-communicable disease risk factors in India.
    Gaur K; Khedar RS; Mangal K; Sharma AK; Dhamija RK; Gupta R
    Diabetes Metab Syndr; 2021; 15(1):343-350. PubMed ID: 33503583
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Applications of Medical Digital Technologies for Noncommunicable Diseases for Follow-Up during the COVID-19 Pandemic.
    Hussein ESE; Al-Shenqiti AM; Ramadan RME
    Int J Environ Res Public Health; 2022 Oct; 19(19):. PubMed ID: 36231982
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Health services for non-communicable diseases have been severely disrupted by COVID-19 based on an analysis of MicroBlog rescue data in Wuhan, China.
    Zhang X; Sun F; Wang Q
    Int J Health Plann Manage; 2022 May; 37(3):1832-1837. PubMed ID: 35034379
    [TBL] [Abstract][Full Text] [Related]  

  • 26. What Happened to People with Non-Communicable Diseases during COVID-19: Implications of H-EDRM Policies.
    Chan EYY; Kim JH; Lo ESK; Huang Z; Hung H; Hung KKC; Wong ELY; Lee EKP; Wong MCS; Wong SYS
    Int J Environ Res Public Health; 2020 Aug; 17(15):. PubMed ID: 32756382
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The resiliency of noncommunicable diseases services during the public health crisis: a lesson from Bangkok, Thailand.
    Pitayarangsarit S; Bhagaman N; Yodmai K; Thangsirikul N; Tipayamongkholgul M
    BMC Health Serv Res; 2023 Apr; 23(1):409. PubMed ID: 37101168
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Health system adaptions to improve care for people living with non-communicable diseases during COVID-19 in low-middle income countries: A scoping review.
    Baatiema L; Sanuade OA; Allen LN; Abimbola S; Hategeka C; Koram KA; Kruk ME
    J Glob Health; 2023 Mar; 13():06006. PubMed ID: 36862142
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Implementation factors of non-communicable disease policies and programmes for children and youth in low-income and middle-income countries: a systematic review.
    Nguyen GT; Gauvreau C; Mansuri N; Wight L; Wong B; Neposlan J; Petricca K; Denburg A
    BMJ Paediatr Open; 2024 Jun; 8(1):. PubMed ID: 38830723
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of the impact of coronavirus disease 19 on hospitalization rates for chronic non-communicable diseases in Brazil.
    Guimarães RA; Policena GM; Paula HDSC; Pedroso CF; Pinheiro RS; Itria A; Braga Neto OO; Teixeira AM; Silva IA; Oliveira GA; Batista KA
    PLoS One; 2022; 17(3):e0265458. PubMed ID: 35324951
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An Implementation Framework for Telemedicine to Address Noncommunicable Diseases in Thailand.
    Chattranukulchai P; Thongtang N; Ophascharoensuk V; Muengtaweepongsa S; Angkurawaranon C; Chalom K; Supungul S; Thammatacharee J; Kittikhun S; Shantavasinkul PC; Leelahavarong P; Rawdaree P; Tangsawad S; Pitayarangsarit S; Kanaderm C; Assawamakin A; Roubsanthisuk W; Sukonthasarn A
    Asia Pac J Public Health; 2021 Nov; 33(8):968-971. PubMed ID: 33870725
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Knowledge of non-communicable diseases and access to healthcare services among adults before and during COVID-19 pandemic in rural Tanzania.
    Sirili N; Kilonzi M; Kiwango G; Lengai E; Nandala R; Mwakawanga DL; Philipo EG; Thobias JM; Frumence G
    Front Public Health; 2024; 12():1342885. PubMed ID: 38605870
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The impact of COVID-19 on the lives of Canadians with and without non-communicable chronic diseases: results from the iCARE Study.
    Deslauriers F; Gosselin-Boucher V; Léger C; Vieira AM; Bacon SL; Lavoie KL
    BMC Public Health; 2023 Oct; 23(1):2106. PubMed ID: 37884921
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Access to Medicines for Non-Communicable Diseases (NCDS) during COVID-19 in Kenya: A Descriptive Commentary.
    Kiragu ZW; Gathecha G; Mwangi MK; Ndegwa Z; Pastakia S; Nyagah D; Cizungu RN; Takah Mutwiri M; Ndolo M; Wirtz VJ
    Health Syst Reform; 2021 Jan; 7(1):e1984865. PubMed ID: 34748436
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The impact of COVID-19 on the care of people living with noncommunicable diseases in low- and middle-income countries: an online survey of physicians and pharmacists in nine countries.
    Bullen C; McCormack J; Calder A; Parag V; Subramaniam K; Majumdar A; Huang PH; Devi R; El Bizri L; Goodyear-Smith F
    Prim Health Care Res Dev; 2021 Jun; 22():e30. PubMed ID: 34120672
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A National Laboratory Perspective: The Impact of the Covid-19 Pandemic on the Management of Patients With Non-Communicable Disease in South Africa: Impact of COVID-19 on patients with noncommunicable diseases - ERRATUM.
    Kruger EC; Van der Westhuizen DJ; Erasmus RT; Banderker RB; Jacob D; Moodley N; Ngxamngxa U; Kengne AP; Zemlin AE
    Disaster Med Public Health Prep; 2024 Feb; 18():e25. PubMed ID: 38356362
    [No Abstract]   [Full Text] [Related]  

  • 37. Surveillance of Noncommunicable Disease Epidemic Through the Integrated Noncommunicable Disease Collaborative Management System: Feasibility Pilot Study Conducted in the City of Ningbo, China.
    Li S; Zhang L; Liu S; Hubbard R; Li H
    J Med Internet Res; 2020 Jul; 22(7):e17340. PubMed ID: 32706706
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Covid-19 pandemic as an opportunity for advances in medicine.
    Bijlani R
    Natl Med J India; 2020; 33(5):316. PubMed ID: 34213469
    [No Abstract]   [Full Text] [Related]  

  • 39. Management of Inflammatory Bowel Disease and COVID-19 in New York City 2020: The Epicenter of IBD in the First Epicenter of the Global Pandemic.
    Kornbluth A; Kissous-Hunt M; George J; Legnani P
    Inflamm Bowel Dis; 2020 Oct; 26(11):1779-1785. PubMed ID: 32879978
    [No Abstract]   [Full Text] [Related]  

  • 40. Impact of the COVID-19 Pandemic on Patients Affected by Non-Communicable Diseases in Europe and in the USA.
    Pécout C; Pain E; Chekroun M; Champeix C; Kulak C; Prieto R; van Vugt J; Gilchrist K; Lainé-Pellet AF
    Int J Environ Res Public Health; 2021 Jun; 18(13):. PubMed ID: 34206293
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.